The FDA approved a new emergency stent device to treat perforations in the blood vessels of the heart, the agency’s first new treatment option in the indication in 17 years. Deep tears in coronary ...

A 42 years old male patient was admitted with resuscitated sudden cardiac death. Electrocardiogram revealed ST segment elevation in leads II, III, and aVF. After crossing the lesion with a floppy ...

Patients with complex coronary artery disease who underwent a stenting procedure guided by intravascular imaging were nearly 40% less likely to die of heart disease, have a heart attack caused by a ...

CHICAGO.-- Northwestern's Bluhm Cardiovascular Institute recently enrolled its first subject in ABSORB III, a clinical trial to study a "disappearing" heart device for the treatment of coronary artery ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced it has approved a coronary stent system for the treatment of patients with acute coronary ...

What is the current thinking with regard to coronary artery bypass grafting vs. stent placement in patients younger than 40 years? Each patient is assessed individually. Most prefer not to have ...

Add Yahoo as a preferred source to see more of our stories on Google. Each year, nearly a million Americans undergo implantation of heart stents. These tiny, wiry tubes of woven metal help prop open ...

"There is little doubt that in combination with a controlled drug-eluting design and a reabsorbable polymer, the use of an absorbable stent will likely become a valuable tool in the future." Coronary ...

Restenosis after coronary stenting necessitates repeated percutaneous or surgical revascularization procedures. The delivery of paclitaxel to the site of vascular injury may reduce the incidence of ...